Back to top

Corporate Summary

 •    Shares of Lam Research Corporation (LRCX - Free Report) gained 6.9% after the company reported third-quarter fiscal 2017 non-GAAP earnings of $2.80 per share, which surpassed the Zacks Consensus Estimate of $2.54

•    Facebook’s (FB - Free Report) shares advanced 0.9% after it announced a new cameras-based augmented reality platform.

•    Shares of Ultragenyx Pharmaceutical Inc (RARE - Free Report) gained 1.4% after the company declared positive data from a phase III study evaluating its pipeline candidate burosumab (KRN23) in adults with X-linked hypophosphatemia (XLH)

•    Abbott Laboratories’ (ABT - Free Report) shares gained 0.4% after the company reported first quarter revenues of $6.33 billion which has surpassed the Zacks Consensus Estimate for revenues of $6.11 billion